Avion Wealth’s Voyager Therapeutics VYGR Stock Holding History

Avion Wealth’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	169	–	–	﹤0.01%	1628
2025 Q4	$0	Hold	169	–	–	﹤0.01%	1616
2025 Q3	$0	Buy	169 +9	+6%	+$33	﹤0.01%	1577
2025 Q2	$0	Buy	+160	New	+$516	﹤0.01%	1642

Other funds holding VYGR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Avion Wealth's VYGR Position: Q1 2026 in Review

Avion Wealth held its Voyager Therapeutics (VYGR) position steady in Q1 2026 at 169 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

Avion Wealth first reported a position in VYGR in Q2 2025 and has held it in 4 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

Avion Wealth held 169 shares of Voyager Therapeutics worth $0 as of Q1 2026.
Avion Wealth left its Voyager Therapeutics share count unchanged in Q1 2026.
Voyager Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1628 holding.
Avion Wealth first reported a position in Voyager Therapeutics in Q2 2025 and has held it in 4 quarters since.
135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.